Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine

Journal of General Virology

Volumn 82, Issue 12, 2001, Pages 2881-2888

  Prince, G A ^a   Curtis, S J ^a   Yim, K C ^a   Porter, D D ^a  

^a Virion Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; LIVE VACCINE; LOT 100; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; INTERSTITIAL PNEUMONIA; LUNG ALVEOLITIS; MALE; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; PROVOCATION TEST; RAT; RAT STRAIN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STANDARD; SUPERINFECTION; VACCINATION; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; GOSSYPIUM HIRSUTUM; RESPIRATORY SYNCYTIAL VIRUS; RNA VIRUSES; SIGMODON; SYNCYTIAL VIRUS;

EID: 0035200723     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-12-2881     Document Type: Article

References (25)

1. Pathological changes in virus infections of the lower respiratory tract in children
2. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein
3. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population
4. + T cells
5. Altered reactivity to measles virus. A typical measles in children previously immunized with inactivated measles virus vaccines
6. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine
7. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology
8. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection
9. Acute immunologic pulmonary alveolitis
10. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge
11. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine
12. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine
13. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
14. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus
15. Detection of respiratory syncytial virus (RSV) infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin-inactivated virus or purified RSV F and G glycoprotein subunit vaccine and challenged with RSV
16. Immune response to experimentally induced infection with respiratory syncytial virus: Possible role in the development of pulmonary disease
17. Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus
18. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon
19. The pathogenesis of respiratory syncytial virus infection in cotton rats
20. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus)
21. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by intramuscular inoculation of formalin-inactivated virus
22. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia
23. A typical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus
24. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice
25. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern